Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-08

Clinical Trial Update: Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab

View source ↗

Summary

A completed clinical trial evaluating the value of a specific dosage of cetuximab for patients with colon cancer or head and neck cancers who are candidates for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetuximab (cetuximab)

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Colon Cancer, Head and Neck Cancer | Status: COMPLETED